Parkinson's disease
The platform assesses cognitive and motor function via at-home assessments that generate digital biomarkers and a predictive score, supporting the early detection of Parkinson's.
The grant will help Verily generate a detailed molecular dataset of Parkinson’s disease, integrating genomic, metabolic, immunologic and digital health data.
Also, Japan has approved one of JLK's stroke imaging AI solutions.
It enables the rapid monitoring of L-dopa levels, informing its optimal dosage adjustment.
The feature provides vibrotactile stimulation when a patient is experiencing freezing of gait, a common symptom of Parkinson's disease.
Also, a new predictive algorithm can predict the survival of a patient on ECMO.
MJFF will use H1's AI-enabled platform to evaluate treatment approaches and improve clinical trial access for patients with Parkinson's from marginalized communities.
AmerisourceBergen will support the distribution of h2o's Apple Watch-enabled prescription digital therapeutic for Parkinson's disease monitoring.
The AI-powered app allows for remote monitoring of common Parkinson's disease symptoms such as bradykinesia, tremor and dyskinesia via an Apple Watch.
BlueRock Therapeutics will utilize Rune Labs' StriveStudy clinical trial platform and FDA-cleared Apple Watch data-collection tool to monitor Parkinson's disease.